SlideShare a Scribd company logo
1 of 37
Download to read offline
BlindedĀ Adaptations,Ā Ā 
PermutationĀ TestsĀ &Ā Tā€Tests
Michael Proschan (NIAID)MichaelĀ ProschanĀ (NIAID)
IntroductionIntroduction
ā€¢ Joint work with Ekkehard Glimm and MartinJointĀ workĀ withĀ Ekkehard Glimm andĀ MartinĀ 
Posch 2014,Ā Stat.Ā inĀ Med.Ā onlineĀ 
ā€¢ SeeĀ alsoĀ Posch &Ā Proschan 2012,Ā Stat.Ā inĀ Med.Ā 
31 4146 415331,Ā 4146ā€4153
IntroductionIntroduction
ā€¢ Clinical trials are preā€meditated!ClinicalĀ trialsĀ areĀ pre meditated!
ā€¢ WeĀ preā€specifyĀ everything
S i it / i f i itā€“ Superiority/noninferiority
ā€“ PopulationĀ (inclusion/exclusionĀ criteria)
ā€“ PrimaryĀ endpoint
ā€“ SecondaryĀ endpoints
ā€“ AnalysisĀ methods
ā€“ SampleĀ size/power
IntroductionIntroduction
ā€¢ Changes made after seeing data are rightlyChangesĀ madeĀ afterĀ seeingĀ dataĀ areĀ rightlyĀ 
questioned:Ā areĀ investigatorsĀ tryingĀ toĀ getĀ anĀ 
unfairĀ advantage?
ā€“ ChangingĀ primaryĀ endpointĀ becauseĀ anotherĀ 
endpointĀ hasĀ aĀ biggerĀ treatmentĀ effect
ā€“ IncreasingĀ sampleĀ sizeĀ becauseĀ theĀ pā€valueĀ isĀ close
ā€“ ChangingĀ primaryĀ analysisĀ becauseĀ ā€œassumptionsĀ 
are violatedā€areĀ violated
ā€“ ChangingĀ populationĀ becauseĀ ofĀ promisingĀ 
subgroup resultssubgroupĀ results
IntroductionIntroduction
ā€¢ Whatā€™s the harm? 0 05 is arbitrary anywayWhat sĀ theĀ harm?Ā Ā 0.05Ā isĀ arbitraryĀ anyway
ā€¢ Problem:Ā ifĀ unlimitedĀ freedomĀ toĀ changeĀ 
anything the real error rate could be hugeanything,Ā theĀ realĀ errorĀ rateĀ couldĀ beĀ huge
ā€¢ ReminiscentĀ ofĀ BibleĀ codeĀ controversy
ā€“ ClairvoyantĀ messagesĀ suchĀ asĀ ā€œBinĀ Ladenā€Ā andĀ 
ā€œtwinĀ towersā€Ā byĀ skippingĀ lettersĀ inĀ OldĀ Testament
ā€“ SimilarĀ messagesĀ canĀ beĀ foundĀ byĀ skippingĀ lettersĀ 
inĀ anyĀ largeĀ bookĀ (BrendanĀ McKay)
IntroductionIntroduction
ā€¢ But changes made before unblinding areButĀ changesĀ madeĀ beforeĀ unblinding areĀ 
different
ā€¢ Under strong null hypothesis that treatmentā€¢ UnderĀ strongĀ nullĀ hypothesis thatĀ treatmentĀ 
hasĀ NO effect,Ā blindedĀ dataĀ giveĀ noĀ infoĀ aboutĀ 
treatment effecttreatmentĀ effect
ā€“ ImpossibleĀ toĀ cheatĀ evenĀ ifĀ itĀ seemsĀ likeĀ cheating
E if bli d d d t h bi d l di t ib ti itā€¢ E.g.,Ā evenĀ ifĀ blindedĀ dataĀ showĀ bimodalĀ distribution,Ā itĀ 
isĀ notĀ causedĀ byĀ treatmentĀ ifĀ strongĀ nullĀ isĀ trueĀ 
Permutation TestsPermutationĀ Tests
ā€¢ Permutation tests condition on all data otherPermutationĀ testsĀ conditionĀ onĀ allĀ dataĀ otherĀ 
thanĀ treatmentĀ labels
ā€¢ Under strong null (D Z ) are independentā€¢ UnderĀ strongĀ null,Ā (D,Z )Ā areĀ independent,Ā 
whereĀ Z areĀ Ā±1Ā treatmentĀ indicatorsĀ &Ā DĀ areĀ 
datadataĀ 
ā€“ ObservedĀ dataĀ DĀ wouldĀ haveĀ beenĀ observedĀ 
regardless of the treatment givenregardlessĀ ofĀ theĀ treatmentĀ given
ā€“ ItĀ isĀ asĀ ifĀ weĀ observedĀ DĀ FIRST,Ā thenĀ madeĀ theĀ 
treatment assignments ZtreatmentĀ assignmentsĀ Z
Permutation TestsPermutationĀ Tests
ā€¢ Peaking at data changes nothing becausePeakingĀ atĀ dataĀ changesĀ nothingĀ becauseĀ 
permutationĀ testsĀ alreadyĀ conditionĀ onĀ D
ā€¢ Conditional distribution of test statistic T(Z Y)ā€¢ ConditionalĀ distributionĀ ofĀ testĀ statisticĀ T(Z,Y)Ā 
givenĀ DĀ isĀ thatĀ ofĀ T(Z,y)Ā whereĀ y isĀ fixed
Di ib i f Z d d d i iā€¢ DistributionĀ ofĀ Z dependsĀ onĀ randomizationĀ 
methodĀ 
ā€“ Simple
ā€“ PermutedĀ block,Ā etc.
Permutation TestsPermutationĀ Tests
T T C C C T C T C C T T C T T C
4 8 4 0 1 3 0 4 4 0 2 5 0 2 1 0
T-C T-C T-C T-C
O ll T C
4.0 3.0 1.5 1.5
Overall T-C
2.5
Permutation TestsPermutationĀ Tests
T C C T C T C T T T C C C T C T
4 8 4 0 1 3 0 4 4 0 2 5 0 2 1 0
T-C T-C T-C T-C
O ll T C
-4.0 3.0 -1.5 0.5
Overall T-C
-0.5
Rerandomization Distribution
PermutationĀ Distribution
100
y
80
Frequency
06004002
11
T-C Mean
-3 -2 -1 0 1 2 3
Blinded 2ā€Stage ProceduresBlindedĀ 2 StageĀ Procedures
ā€¢ Blinded 2ā€stage adaptive procedures use 1stBlindedĀ 2 stageĀ adaptiveĀ proceduresĀ useĀ 1stĀ Ā 
stageĀ toĀ makeĀ designĀ changes
ā€“ SampleĀ sizeĀ (Gould,Ā 1992,Ā Stat.Ā inĀ Med.Ā 11,Ā 55ā€66;Ā p ( , , , ;
GouldĀ &Ā Shih,Ā 1992Ā Commun.Ā inĀ Stat.Ā 21,Ā 2833ā€
2853)Ā 
P i d i ( di li liā€“ PrimaryĀ endpointĀ (e.g.,Ā diastolicĀ versusĀ systolicĀ 
bloodĀ pressure)
ā€¢ Previous argument shows that if adaptation isā€¢ PreviousĀ argumentĀ showsĀ thatĀ ifĀ adaptationĀ isĀ 
madeĀ beforeĀ unblinding,Ā aĀ permutationĀ testĀ 
on 1st stage data is still validonĀ 1stĀ stageĀ dataĀ isĀ stillĀ valid
Blinded 2ā€Stage ProceduresBlindedĀ 2 StageĀ Procedures
ā€¢ Careful! Subtle errors are possibleCareful!Ā Ā SubtleĀ errorsĀ areĀ possible
ā€¢ E.g.,Ā inĀ adaptiveĀ regression,Ā whichĀ ofĀ theĀ 
following is (are) valid?followingĀ isĀ (are)Ā valid?
1. FromĀ ANCOVAsĀ Y=Ī²01+Ī²z+Ī²ixi,Ā i=1,ā€¦,k,Ā pickĀ xi
that minimizes MSE; do permutation test onthatĀ minimizesĀ MSE;Ā doĀ permutationĀ testĀ onĀ 
winner
2 From ANCOVAs Y=Ī² 1+Ī² x i=1 k pick x that2. FromĀ ANCOVAsĀ Y=Ī²01+Ī²ixi,Ā i=1,ā€¦,k,Ā pickĀ xi thatĀ 
minimizesĀ MSE;Ā doĀ permutationĀ testĀ onĀ 
Y=Ī²01+Ī²z+Ī²*x*,Ā whereĀ x*Ā isĀ winnerĪ²0 Ī² Ī² ,
Blinded 2ā€Stage ProceduresBlindedĀ 2 StageĀ Procedures
ā€¢ Careful! Subtle errors are possibleCareful!Ā Ā SubtleĀ errorsĀ areĀ possible
ā€¢ E.g.,Ā inĀ adaptiveĀ regression,Ā whichĀ ofĀ theĀ 
following is (are) valid?followingĀ isĀ (are)Ā valid?
1. FromĀ ANCOVAsĀ Y=Ī²01+Ī²z+Ī²ixi,Ā i=1,ā€¦,k,Ā pickĀ xi
that minimizes MSE; do permutation test onthatĀ minimizesĀ MSE;Ā doĀ permutationĀ testĀ onĀ 
winner
2 From ANCOVAs Y=Ī² 1+Ī² x i=1 k pick x that2. FromĀ ANCOVAsĀ Y=Ī²01+Ī²ixi,Ā i=1,ā€¦,k,Ā pickĀ xi thatĀ 
minimizesĀ MSE;Ā doĀ permutationĀ testĀ onĀ 
Y=Ī²01+Ī²z+Ī²*x*,Ā whereĀ x*Ā isĀ winnerĪ²0 Ī² Ī² ,
Blinded 2ā€Stage ProceduresBlindedĀ 2 StageĀ Procedures
ā€¢ Unblinding andĀ apparentĀ Ī±ā€inflationĀ alsoĀ possibleĀ U b d g a d appa e t Ī± at o a so poss b e
ifĀ strongĀ nullĀ isĀ false
ā€¢ E.g.,Ā changeĀ primaryĀ endpointĀ basedĀ onĀ ā€œblindedā€Ā g g p y p
dataĀ (X,Y1,Y2),Ā Y1 andĀ Y2 areĀ potentialĀ primariesĀ 
andĀ X=levelĀ ofĀ studyĀ drugĀ inĀ blood
ā€“ XĀ completelyĀ unblinds
ā€“ CanĀ thenĀ pickĀ Y1 orĀ Y2 withĀ biggestĀ zā€score
Clearly inflates Ī±ā€“ ClearlyĀ inflatesĀ Ī±
ā€“ Problem:Ā strongĀ nullĀ requiresĀ noĀ effectĀ onĀ ANY
variableĀ examinedĀ (includingĀ X=levelĀ ofĀ studyĀ drug)
Blinded 2ā€Stage ProceduresBlindedĀ 2 StageĀ Procedures
ā€¢ Claim: the following procedure is validClaim:Ā theĀ followingĀ procedureĀ isĀ valid
ā€“ AfterĀ viewingĀ 1stĀ stageĀ dataĀ D1,Ā chooseĀ testĀ 
statistic T1(Y1 Z1) and second stage data to collectstatisticĀ T1(Y1,Z1)Ā andĀ secondĀ stageĀ dataĀ toĀ collect
ā€“ AfterĀ observingĀ D2,Ā chooseĀ T2(Y2,Z2)Ā andĀ methodĀ 
of combining T1 and T2, f(T1,T2)ofĀ combiningĀ T1 andĀ T2,Ā f(T1,T2)
ā€“ ConditionalĀ distributionĀ ofĀ f(T1,T2)Ā givenĀ (D1,D2)Ā isĀ 
itsĀ stratifiedĀ permutationĀ distributionp
ā€“ StratifiedĀ permutationĀ testĀ controlsĀ conditional,Ā &Ā 
thereforeĀ unconditionalĀ typeĀ IĀ errorĀ rateĀ 
Focus of Rest of TalkFocusĀ ofĀ RestĀ ofĀ Talk
ā€¢ Permutation tests are asymptoticallyPermutationĀ testsĀ areĀ asymptoticallyĀ 
equivalentĀ toĀ tā€tests
ā€¢ Suggests that adaptive t tests might be valid ifā€¢ SuggestsĀ thatĀ adaptiveĀ tā€testsĀ mightĀ beĀ validĀ ifĀ 
adaptiveĀ permutationĀ testsĀ are
W id i bā€¢ WeĀ considerĀ connectionsĀ betweenĀ 
permutationĀ andĀ tā€tests,Ā andĀ validityĀ ofĀ 
d i f d i iadaptiveĀ tā€testsĀ fromĀ adaptiveĀ permutationĀ 
testsĀ 
Oneā€Sample CaseOne SampleĀ Case
ā€¢ CommunityĀ randomizedĀ trialsĀ sometimesĀ pairĀ Co u ty a do ed t a s so et es pa
matchĀ &Ā randomizeĀ withinĀ pairs
ā€¢ E.g.,Ā COMMITĀ trialĀ usedĀ communityĀ interventionĀ g y
toĀ helpĀ peopleĀ quitĀ smokingā€”11Ā matchedĀ pairs
ā€¢ D=differenceĀ inĀ quitĀ ratesĀ betweenĀ treatmentĀ (T)Ā 
&Ā controlĀ (C)
T CĀ Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā D=Tā€C
PairĀ iĀ Ā Ā Ā Ā Ā Ā Ā Ā 0.30Ā Ā Ā Ā Ā 0.25Ā Ā Ā Ā Ā Ā Ā Ā +0.05
Oneā€Sample CaseOne SampleĀ Case
ā€¢ CommunityĀ randomizedĀ trialsĀ sometimesĀ pairĀ Co u ty a do ed t a s so et es pa
matchĀ &Ā randomizeĀ withinĀ pairs
ā€¢ E.g.,Ā COMMITĀ trialĀ usedĀ communityĀ interventionĀ g y
toĀ helpĀ peopleĀ quitĀ smokingā€”11Ā matchedĀ pairs
ā€¢ D=differenceĀ inĀ quitĀ ratesĀ betweenĀ treatmentĀ (T)Ā 
&Ā controlĀ (C)
C TĀ  D=Tā€C
PairĀ iĀ Ā Ā Ā Ā Ā Ā Ā Ā 0.30Ā Ā Ā Ā Ā 0.25Ā Ā Ā Ā Ā Ā Ā Ā ā€0.05
Oneā€Sample CaseOne SampleĀ Case
ā€¢ Permuting labels changes only sign of DPermutingĀ labelsĀ changesĀ onlyĀ signĀ ofĀ D
ā€¢ PermutationĀ testĀ conditionsĀ onĀ |Di|=Ā di
+;Ā 
d + d d + ll lik lā€di
+Ā andĀ di
+ areĀ equallyĀ likely
ā€¢ The permutation distribution of ļ“Di is dist. ofTheĀ permutationĀ distributionĀ ofĀ ļ“Di isĀ dist.Ā of
21w p1where /ZdZ ļ€­ļ€½ļƒ„ ļ€«
21w.p.1
21w.p.1where,
/
/ZdZ iii
ļ€«
ļ€½ļƒ„
Oneā€Sample CaseOne SampleĀ Case
ā€¢ InĀ 1st stage,Ā adaptĀ basedĀ onĀ |D1|,ā€¦,|Dn|Ā (blinded)g , p | 1|, ,| n| ( )
ā€“ E.g.,Ā increaseĀ stageĀ 2Ā Ā sampleĀ sizeĀ becauseĀ |Di|Ā isĀ veryĀ 
large
ā€¢ What is conditional distribution of 1st stage sumā€¢ WhatĀ isĀ conditionalĀ distributionĀ ofĀ Ā 1st stageĀ sumĀ 
Ī£Di givenĀ |D1|=d1
+,ā€¦,|Dn|= dn
+ andĀ theĀ 
adaptation?adaptation?
ā€“ TheĀ adaptationĀ isĀ aĀ functionĀ ofĀ |D1|,ā€¦,|Dn|Ā 
ā€“ TheĀ nullĀ distributionĀ ofĀ Ī£Di givenĀ |D1|=d1
+,ā€¦,|Dn|=Ā dn
+
i g | 1| 1 , ,| n| n
ISĀ itsĀ permutationĀ distribution
ā€“ Conclusion:Ā permutationĀ testĀ onĀ stageĀ 1Ā dataĀ stillĀ valid
Oneā€Sample CaseOne SampleĀ Case
ā€¢ Mean and variance of permutationMeanĀ andĀ varianceĀ ofĀ permutationĀ 
distributionĀ are
ļ€Ø ļ€© ļƒ„ļƒ„ ļ€½ļ€½ ļ€«ļ€«
0)(E iiii ZEddZļ€Ø ļ€©
ļ€Ø ļ€© ļƒ„ļƒ„ļƒ„
ļƒ„ļƒ„
ļ€½ļ€½ļ€« 222
)(var
)(
iiiii
iiii
dZEddZ
Oneā€Sample CaseOne SampleĀ Case
ā€¢ Asymptotically,Ā permutationĀ distributionĀ isĀ sy ptot ca y, pe utat o d st but o s
normalĀ withĀ thisĀ meanĀ andĀ varianceĀ (Lindebergā€
FellerĀ CLT)
ā€¢ I.e.,Ā conditionalĀ distributionĀ ofĀ ļ“Di givenĀ , i g
|D1|=d1
+,ā€¦,|Dn|=Ā dn
+ isĀ asymptoticallyĀ N(0,ļ“di
2)
ā€¢ DependsĀ onĀ |D1|=d1
+,ā€¦,|Dn|=Ā dn
+ onlyĀ throughĀ 
L2=ļ“di
2L ļ“di
Oneā€Sample CaseOne SampleĀ Case
ā€¢ Asymptotically, permutation distribution ofAsymptotically,Ā permutationĀ distributionĀ ofĀ 
ļ€Ø ļ€© N
d
dN
D
D
T ii
2
2
2
)1,0(
,0
' ļ€½ļ‚»ļ€½
ļƒ„
ļƒ„
ļƒ„
ļƒ„
LD
dD ii
2
ļƒ„
ļƒ„ļƒ„
n
L
Dns
ns
D
T i
i
2
22
02
0
)/1(;' ļ€½ļ€½ļ€½ ļƒ„ļƒ„
ā€¢ LikeĀ tā€testĀ withĀ varianceĀ estimateĀ s0
2 insteadĀ 
ofĀ usualĀ sampleĀ varianceĀ s2
Oneā€Sample CaseOne SampleĀ Case
ā€¢ Recap: Permutation distribution of Tā€™ is dist ofRecap:Ā PermutationĀ distributionĀ ofĀ T isĀ distĀ ofĀ 
ļƒ„
ļƒ„ļ€½ 12
|||,...,|given' n
i
DD
D
D
T
ļƒ„
ļƒ„
2
i'
i
DT
D
ļ€Ø ļ€©ļƒ„
ļƒ„ļ‚»
22
2
d dtd ')10(
given' i
DLN
DT
ā€¢ Conclusion:Ā Tā€™ isĀ asymptoticallyĀ indep ofĀ L2
ļ€Ø ļ€©ļƒ„ļ€½ļ‚» 22
ondependtdoesn')1,0( iDLN
Oneā€Sample CaseOne SampleĀ Case
ā€¢ Begs question, is this true for all sample sizesBegsĀ question,Ā isĀ thisĀ trueĀ forĀ allĀ sampleĀ sizesĀ 
underĀ normalityĀ assumption?
ā€¢ if Di are iid N(0,ļ³2), then canifĀ Di areĀ iid N(0,ļ³ ),Ā thenĀ can
?fti d db' 2
ļƒ„ļƒ„ i
D
D
T ?oftindependenbe' 2
2 ļƒ„
ļƒ„
ļƒ„ļ€½ i
i
i
D
D
T
ā€¢ SeemsĀ crazy,Ā butĀ itā€™sĀ true!
Oneā€Sample CaseOne SampleĀ Case
ā€¢ One way to see that Tā€™ is independent of ļ“Di
2OneĀ wayĀ toĀ seeĀ thatĀ T isĀ independentĀ ofĀ ļ“Di
usesĀ Basuā€™s theorem:Ā 
ā€¢ RecallĀ SĀ isĀ sufficient forĀ Īø ifĀ F(y|s)Ā doesĀ notĀ 
d d Īø i i l if { ( )} f ll ĪødependĀ onĀ Īø;Ā itĀ isĀ complete ifĀ E{g(S)}=0Ā forĀ allĀ Īø
impliesĀ g(S)ā‰”0Ā withĀ probabilityĀ 1
ā€¢ A is ancillary if its distribution does not dependā€¢ AĀ isĀ ancillary ifĀ itsĀ distributionĀ doesĀ notĀ dependĀ 
onĀ Īø
ā€¢ Basu,Ā 1955,Ā Sankhya 15,Ā 377ā€380:
IfĀ SĀ isĀ aĀ complete,Ā sufficientĀ statisticĀ andĀ AĀ 
isĀ ancillary,Ā thenĀ SĀ andĀ AĀ areĀ independent
Oneā€Sample CaseOne SampleĀ Case
ā€¢ Consider Di iid N(0 ļ³2) with ļ³2Ā unknownConsiderĀ Di iid N(0,ļ³ )Ā withĀ ļ³ unknown
ā€“ļ“Di
2 isĀ completeĀ andĀ sufficient
ā€“ Tā€™=Ā ļ“Di/(ļ“Di
2)1/2 isĀ ancillaryĀ becauseĀ itĀ isĀ scaleā€
invariant
ā€“ ByĀ Basuā€™s theorem,Ā Tā€™ andĀ ļ“Di
2 areĀ independent
Oneā€Sample CaseOne SampleĀ Case
ā€¢ Same argument shows that the usual tā€SameĀ argumentĀ showsĀ thatĀ theĀ usualĀ t
statisticĀ isĀ independentĀ ofĀ ļ“Di
2
2 2ā€¢ UnderĀ Di iid N(0,ļ³2)Ā withĀ ļ³2Ā unknown
ā€“ļ“Di
2 isĀ completeĀ andĀ sufficient
ā€“ UsualĀ tā€statisticĀ T=Ā ļ“Di/(ns2)1/2 isĀ ancillary
ā€“ By Basuā€™s theorem T and ļ“D 2 are independentā€“ ByĀ Basu s theorem,Ā TĀ andĀ ļ“Di areĀ independentĀ 
(Ā Shao (2003):Ā MathematicalĀ Statistics,Ā Springer)Ā 
Oneā€Sample CaseOne SampleĀ Case
ā€¢ This result is important for adaptive sample sizeThisĀ resultĀ isĀ important forĀ adaptiveĀ sampleĀ sizeĀ 
calculations
ā€“ Stage 1 with n1= half of original sample size: changeStageĀ 1Ā withĀ n1 Ā halfĀ ofĀ originalĀ sampleĀ size:Ā changeĀ 
secondĀ stageĀ sampleĀ sizeĀ toĀ n2=n2(Ī£Di
2)
ā€“ Conditioned on Ī£D 2:ā€“ ConditionedĀ onĀ Ī£Di :Ā 
ā€¢ TestĀ statisticĀ T1 hasĀ exactĀ tā€distributionĀ withĀ n1ā€1Ā d.f.
ā€¢ TestĀ statisticĀ T2 hasĀ exactĀ tā€distributionĀ withĀ n2ā€1Ā d.f. andĀ isĀ 2 2
independentĀ ofĀ T1
ā€¢ Pā€valuesĀ P1 andĀ P2 areĀ independentĀ U(0,1)
ā€¢ Y={n 1/2Ī¦ā€1(P )+n 1/2Ī¦ā€1(P )}/(n +n )1/2 is N(0 1) under Hā€¢ Y={n1
1/2Ī¦ 1(P1)+n2
1/2Ī¦ 1(P2)}/(n1+n2)1/2 isĀ N(0,1)Ā underĀ H0
Oneā€Sample CaseOne SampleĀ Case
ā€¢ Reject if Y>zRejectĀ ifĀ Y>zĪ±
ā€¢ ConditionedĀ onĀ Ī£Di
2,Ā typeĀ IĀ errorĀ rateĀ isĀ Ī±
ā€¢ UnconditionalĀ typeĀ IĀ errorĀ rateĀ isĀ Ī± asĀ well
ā€¢ Most other twoā€stage procedures are onlyMostĀ otherĀ two stageĀ proceduresĀ areĀ onlyĀ 
approximate
Oneā€Sample CaseOne SampleĀ Case
ā€¢ CouldĀ evenĀ makeĀ otherĀ adaptationsĀ likeĀ changingĀ p g g
primaryĀ endpoint
ā€¢ LookĀ atĀ Ī£Di
2 forĀ eachĀ endpointĀ andĀ determineĀ 
whichĀ oneĀ isĀ primaryĀ Ā 
ļ“ 2ā€“ E.g.,Ā pickĀ endpointĀ withĀ smallestĀ ļ“Di
2
ā€¢ Slight generalization of our result shows thatā€¢ SlightĀ generalizationĀ ofĀ ourĀ resultĀ showsĀ thatĀ 
conditionalĀ distributionĀ ofĀ TĀ givenĀ adaptation isĀ 
stillĀ exactĀ tĀ 
Oneā€Sample CaseOne SampleĀ Case
ā€¢ Shows that conditional type I error rate givenShowsĀ thatĀ conditionalĀ typeĀ IĀ errorĀ rateĀ givenĀ 
adaptationĀ isĀ controlledĀ atĀ levelĀ Ī±
ā€¢ Unconditional type I error rate must also beā€¢ UnconditionalĀ typeĀ IĀ errorĀ rateĀ mustĀ alsoĀ beĀ 
controlledĀ atĀ levelĀ Ī±
D i i l i i liā€¢ DerivationĀ assumesĀ multivariateĀ normalityĀ 
withĀ variance/covarianceĀ notĀ dependingĀ onĀ 
mean
Twoā€Sample CaseTwo SampleĀ Case
ā€¢ CanĀ useĀ sameĀ reasoningĀ inĀ 2ā€sampleĀ settingĀ Ca use sa e easo g sa p e sett g
ā€¢ WithĀ equalĀ sampleĀ sizes,Ā theĀ numeratorĀ is
ļƒ„ļƒ„ļƒ„ YZYY
ā€¢ Permutation distribution is distribution of
ļƒ„ļƒ„ļƒ„ ļ€½ļ€­ ii
C
i
T
i YZYY
PermutationĀ distributionĀ isĀ distributionĀ ofĀ 
ļƒ„ļƒ„ ļ€½ļ‚±ļ€½ 0,1each, iiii ZZyZ
ā€¢ LetĀ sL
2 beĀ ā€œlumpedā€Ā varianceĀ ofĀ allĀ dataĀ 
(treatment and control)(treatmentĀ andĀ control)Ā 
Twoā€Sample CaseTwo SampleĀ Case
ā€¢ MeanĀ andĀ varianceĀ ofĀ permutationĀ distributionĀ p
are
ļ€Ø ļ€© 0)(EE iiii ZyyZ ļ€½ļ€½ ļƒ„ļƒ„
ļ€Ø ļ€© 22
)(
1
1
var Lii syy
n
yZ ļ€½ļ€­ļƒ·
ļƒø
ļƒ¶
ļƒ§
ļƒØ
ļƒ¦
ļ€­
ļ€½ ļƒ„ļƒ„
ā€¢ Basuā€™s theoremĀ showsĀ usualĀ 2ā€sampleĀ TĀ isĀ 
independent of sL
2 under null hypothesis ofindependentĀ ofĀ sL underĀ nullĀ hypothesisĀ ofĀ 
commonĀ mean
ā€¢ ConditionalĀ distributionĀ ofĀ TĀ givenĀ sL
2 isĀ stillĀ t
Twoā€Sample CaseTwo SampleĀ Case
ā€¢ Twoā€stage procedureTwo stageĀ procedure
ā€“ StageĀ 1:Ā lookĀ atĀ lumpedĀ varianceĀ andĀ changeĀ stageĀ 
2Ā sampleĀ size
ā€“ ConditionedĀ onĀ 1stĀ stageĀ lumpedĀ varianceĀ &Ā H0
ā€¢ T1 hasĀ tā€distributionĀ withĀ n1ā€2Ā d.f.
ā€¢ T2 hasĀ tā€distributionĀ withĀ n2ā€2Ā d.f. &Ā independentĀ ofĀ T1
ā€¢ Pā€valuesĀ P1 andĀ P2 areĀ independentĀ uniforms
ā€¢ {n1
1/2Ī¦ā€1(P1)+n2
1/2Ī¦ā€1(P2)}/(n1+n2)1/2 is N(0 1) under H0{n1 Ī¦ (P1)+n2 Ī¦ (P2)}/(n1+n2) isĀ N(0,1)Ā underĀ H0
ā€“ ControlsĀ typeĀ IĀ errorĀ rateĀ conditionallyĀ andĀ 
unconditionally
SummarySummary
ā€¢ Permutation tests are often valid even inPermutationĀ testsĀ areĀ oftenĀ validĀ evenĀ inĀ 
adaptiveĀ settingsĀ ifĀ blindĀ isĀ maintained
ā€¢ There is a close connection betweenā€¢ ThereĀ isĀ aĀ closeĀ connectionĀ betweenĀ 
permutationĀ testsĀ andĀ tā€tests
C d d lidi f d i fā€¢ CanĀ deduceĀ validityĀ ofĀ adaptiveĀ tā€testsĀ fromĀ 
validityĀ ofĀ adaptiveĀ permutationĀ tests

More Related Content

What's hot

2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...Cytel USA
Ā 
Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related  Quality-of-life AssessmentRobust Methods for Health-related  Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessmentdylanturner22
Ā 
Sample size for phase ii clinical trials-Simons design and mcp mod case studies
Sample size for phase ii clinical trials-Simons design and mcp mod case studies Sample size for phase ii clinical trials-Simons design and mcp mod case studies
Sample size for phase ii clinical trials-Simons design and mcp mod case studies nQuery
Ā 
Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life AssessmentRobust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessmentdylanturner22
Ā 
Measures and feedback 2016
Measures and feedback 2016Measures and feedback 2016
Measures and feedback 2016Scott Miller
Ā 
2010 smg training_cardiff_day1_session3_higgins
2010 smg training_cardiff_day1_session3_higgins2010 smg training_cardiff_day1_session3_higgins
2010 smg training_cardiff_day1_session3_higginsrgveroniki
Ā 
Innovative sample size methods for adaptive clinical trials webinar web ver...
Innovative sample size methods for adaptive clinical trials webinar   web ver...Innovative sample size methods for adaptive clinical trials webinar   web ver...
Innovative sample size methods for adaptive clinical trials webinar web ver...nQuery
Ā 
Ct lecture 8. comparing two groups categorical data
Ct lecture 8. comparing two groups   categorical dataCt lecture 8. comparing two groups   categorical data
Ct lecture 8. comparing two groups categorical dataHau Pham
Ā 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBhaswat Chakraborty
Ā 

What's hot (9)

2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
Ā 
Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related  Quality-of-life AssessmentRobust Methods for Health-related  Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessment
Ā 
Sample size for phase ii clinical trials-Simons design and mcp mod case studies
Sample size for phase ii clinical trials-Simons design and mcp mod case studies Sample size for phase ii clinical trials-Simons design and mcp mod case studies
Sample size for phase ii clinical trials-Simons design and mcp mod case studies
Ā 
Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life AssessmentRobust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessment
Ā 
Measures and feedback 2016
Measures and feedback 2016Measures and feedback 2016
Measures and feedback 2016
Ā 
2010 smg training_cardiff_day1_session3_higgins
2010 smg training_cardiff_day1_session3_higgins2010 smg training_cardiff_day1_session3_higgins
2010 smg training_cardiff_day1_session3_higgins
Ā 
Innovative sample size methods for adaptive clinical trials webinar web ver...
Innovative sample size methods for adaptive clinical trials webinar   web ver...Innovative sample size methods for adaptive clinical trials webinar   web ver...
Innovative sample size methods for adaptive clinical trials webinar web ver...
Ā 
Ct lecture 8. comparing two groups categorical data
Ct lecture 8. comparing two groups   categorical dataCt lecture 8. comparing two groups   categorical data
Ct lecture 8. comparing two groups categorical data
Ā 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug Products
Ā 

Viewers also liked

2014 EUGM - Blinded Adaptations, Permutations Tests and T Tests
2014 EUGM - Blinded Adaptations, Permutations Tests and T Tests2014 EUGM - Blinded Adaptations, Permutations Tests and T Tests
2014 EUGM - Blinded Adaptations, Permutations Tests and T TestsCytel USA
Ā 
Eugm 2012 unknown - incivex drug development process overview road to findi...
Eugm 2012   unknown - incivex drug development process overview road to findi...Eugm 2012   unknown - incivex drug development process overview road to findi...
Eugm 2012 unknown - incivex drug development process overview road to findi...Cytel USA
Ā 
EUGM 2011 | JEHL | group sequential designs with 2 time to event endpoints
EUGM 2011 | JEHL | group sequential designs with 2 time to event endpointsEUGM 2011 | JEHL | group sequential designs with 2 time to event endpoints
EUGM 2011 | JEHL | group sequential designs with 2 time to event endpointsCytel USA
Ā 
BĆ”o cĆ”o tį»•ng kįŗæt thį»±c tįŗ­p athena
BĆ”o cĆ”o tį»•ng kįŗæt thį»±c tįŗ­p athenaBĆ”o cĆ”o tį»•ng kįŗæt thį»±c tįŗ­p athena
BĆ”o cĆ”o tį»•ng kįŗæt thį»±c tįŗ­p athenaQuĆ½ Đį»“ng Nast
Ā 
Eugm 2012 gaydos - design and analysis approaches to evaluate cardiovascula...
Eugm 2012   gaydos - design and analysis approaches to evaluate cardiovascula...Eugm 2012   gaydos - design and analysis approaches to evaluate cardiovascula...
Eugm 2012 gaydos - design and analysis approaches to evaluate cardiovascula...Cytel USA
Ā 
BĆ”o cĆ”o thį»±c tįŗ­p - Lįŗ§n 1 - HoĆ ng Thanh QuĆ½
BĆ”o cĆ”o thį»±c tįŗ­p - Lįŗ§n 1 - HoĆ ng Thanh QuĆ½BĆ”o cĆ”o thį»±c tįŗ­p - Lįŗ§n 1 - HoĆ ng Thanh QuĆ½
BĆ”o cĆ”o thį»±c tįŗ­p - Lįŗ§n 1 - HoĆ ng Thanh QuĆ½QuĆ½ Đį»“ng Nast
Ā 
Tį»•ng kįŗæt BĆ”o cĆ”o thį»±c tįŗ­p Athena - HoĆ ng Thanh QuĆ½
Tį»•ng kįŗæt BĆ”o cĆ”o thį»±c tįŗ­p Athena - HoĆ ng Thanh QuĆ½Tį»•ng kįŗæt BĆ”o cĆ”o thį»±c tįŗ­p Athena - HoĆ ng Thanh QuĆ½
Tį»•ng kįŗæt BĆ”o cĆ”o thį»±c tįŗ­p Athena - HoĆ ng Thanh QuĆ½QuĆ½ Đį»“ng Nast
Ā 
How to select anĀ Engine Hoist
How to select anĀ Engine HoistHow to select anĀ Engine Hoist
How to select anĀ Engine HoistBrad Evans
Ā 
Campionato mondiale di calcio 2014
Campionato mondiale di calcio 2014Campionato mondiale di calcio 2014
Campionato mondiale di calcio 2014markarnold100
Ā 
Sistema dei commenti conciliante
Sistema dei commenti concilianteSistema dei commenti conciliante
Sistema dei commenti concilianteChessLogger
Ā 
A Bayesian Industry Approach to Phase 1 Combination Trials in Oncology
A Bayesian Industry Approach to Phase 1 Combination Trials in OncologyA Bayesian Industry Approach to Phase 1 Combination Trials in Oncology
A Bayesian Industry Approach to Phase 1 Combination Trials in OncologyCytel USA
Ā 

Viewers also liked (12)

2014 EUGM - Blinded Adaptations, Permutations Tests and T Tests
2014 EUGM - Blinded Adaptations, Permutations Tests and T Tests2014 EUGM - Blinded Adaptations, Permutations Tests and T Tests
2014 EUGM - Blinded Adaptations, Permutations Tests and T Tests
Ā 
Eugm 2012 unknown - incivex drug development process overview road to findi...
Eugm 2012   unknown - incivex drug development process overview road to findi...Eugm 2012   unknown - incivex drug development process overview road to findi...
Eugm 2012 unknown - incivex drug development process overview road to findi...
Ā 
EUGM 2011 | JEHL | group sequential designs with 2 time to event endpoints
EUGM 2011 | JEHL | group sequential designs with 2 time to event endpointsEUGM 2011 | JEHL | group sequential designs with 2 time to event endpoints
EUGM 2011 | JEHL | group sequential designs with 2 time to event endpoints
Ā 
BĆ”o cĆ”o tį»•ng kįŗæt thį»±c tįŗ­p athena
BĆ”o cĆ”o tį»•ng kįŗæt thį»±c tįŗ­p athenaBĆ”o cĆ”o tį»•ng kįŗæt thį»±c tįŗ­p athena
BĆ”o cĆ”o tį»•ng kįŗæt thį»±c tįŗ­p athena
Ā 
Eugm 2012 gaydos - design and analysis approaches to evaluate cardiovascula...
Eugm 2012   gaydos - design and analysis approaches to evaluate cardiovascula...Eugm 2012   gaydos - design and analysis approaches to evaluate cardiovascula...
Eugm 2012 gaydos - design and analysis approaches to evaluate cardiovascula...
Ā 
BĆ”o cĆ”o thį»±c tįŗ­p - Lįŗ§n 1 - HoĆ ng Thanh QuĆ½
BĆ”o cĆ”o thį»±c tįŗ­p - Lįŗ§n 1 - HoĆ ng Thanh QuĆ½BĆ”o cĆ”o thį»±c tįŗ­p - Lįŗ§n 1 - HoĆ ng Thanh QuĆ½
BĆ”o cĆ”o thį»±c tįŗ­p - Lįŗ§n 1 - HoĆ ng Thanh QuĆ½
Ā 
Tį»•ng kįŗæt BĆ”o cĆ”o thį»±c tįŗ­p Athena - HoĆ ng Thanh QuĆ½
Tį»•ng kįŗæt BĆ”o cĆ”o thį»±c tįŗ­p Athena - HoĆ ng Thanh QuĆ½Tį»•ng kįŗæt BĆ”o cĆ”o thį»±c tįŗ­p Athena - HoĆ ng Thanh QuĆ½
Tį»•ng kįŗæt BĆ”o cĆ”o thį»±c tįŗ­p Athena - HoĆ ng Thanh QuĆ½
Ā 
BRAND NURTURING
BRAND NURTURINGBRAND NURTURING
BRAND NURTURING
Ā 
How to select anĀ Engine Hoist
How to select anĀ Engine HoistHow to select anĀ Engine Hoist
How to select anĀ Engine Hoist
Ā 
Campionato mondiale di calcio 2014
Campionato mondiale di calcio 2014Campionato mondiale di calcio 2014
Campionato mondiale di calcio 2014
Ā 
Sistema dei commenti conciliante
Sistema dei commenti concilianteSistema dei commenti conciliante
Sistema dei commenti conciliante
Ā 
A Bayesian Industry Approach to Phase 1 Combination Trials in Oncology
A Bayesian Industry Approach to Phase 1 Combination Trials in OncologyA Bayesian Industry Approach to Phase 1 Combination Trials in Oncology
A Bayesian Industry Approach to Phase 1 Combination Trials in Oncology
Ā 

Similar to 2014-10-22 EUGM | PROSCHAN | Blinded Adaptations Permutations Tests and T-Tests

Intro to tests of significance qualitative
Intro to tests of significance qualitativeIntro to tests of significance qualitative
Intro to tests of significance qualitativePandurangi Raghavendra
Ā 
Sample determinants and size
Sample determinants and sizeSample determinants and size
Sample determinants and sizeTarek Tawfik Amin
Ā 
T test for two independent samples and induction
T test for two independent samples and inductionT test for two independent samples and induction
T test for two independent samples and inductionEmmanuel Buah
Ā 
slides Testing of hypothesis.pptx
slides Testing  of  hypothesis.pptxslides Testing  of  hypothesis.pptx
slides Testing of hypothesis.pptxssuser504dda
Ā 
t-test
t-test t-test
t-test o997
Ā 
Crash Course in A/B testing
Crash Course in A/B testingCrash Course in A/B testing
Crash Course in A/B testingWayne Lee
Ā 
Randomized trials ii dr.wah
Randomized trials ii dr.wahRandomized trials ii dr.wah
Randomized trials ii dr.wahMmedsc Hahm
Ā 
Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptx
Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptxChemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptx
Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptxHakimuNsubuga2
Ā 
An introduction to the stepped wedge cluster randomised trial
An introduction to the stepped wedge cluster randomised trial An introduction to the stepped wedge cluster randomised trial
An introduction to the stepped wedge cluster randomised trial Karla hemming
Ā 
A05 Continuous One Variable Stat Tests
A05 Continuous One Variable Stat TestsA05 Continuous One Variable Stat Tests
A05 Continuous One Variable Stat TestsLeanleaders.org
Ā 
A05 Continuous One Variable Stat Tests
A05 Continuous One Variable Stat TestsA05 Continuous One Variable Stat Tests
A05 Continuous One Variable Stat TestsLeanleaders.org
Ā 
The Blueprint for Success for Effective and Efficient Clinical Protocols.pptx
The Blueprint for Success for Effective and Efficient Clinical Protocols.pptxThe Blueprint for Success for Effective and Efficient Clinical Protocols.pptx
The Blueprint for Success for Effective and Efficient Clinical Protocols.pptxMMS Holdings
Ā 
Parametric Tolerance Interval Testing
Parametric Tolerance Interval TestingParametric Tolerance Interval Testing
Parametric Tolerance Interval TestingSiva Chaitanya Addala
Ā 
Monitoring response variables 13Feb2014
Monitoring response variables 13Feb2014Monitoring response variables 13Feb2014
Monitoring response variables 13Feb2014Thira Woratanarat
Ā 
Test of significance
Test of significanceTest of significance
Test of significanceDr. Imran Zaheer
Ā 

Similar to 2014-10-22 EUGM | PROSCHAN | Blinded Adaptations Permutations Tests and T-Tests (20)

Statistics
StatisticsStatistics
Statistics
Ā 
Intro to tests of significance qualitative
Intro to tests of significance qualitativeIntro to tests of significance qualitative
Intro to tests of significance qualitative
Ā 
Sample determinants and size
Sample determinants and sizeSample determinants and size
Sample determinants and size
Ā 
T test for two independent samples and induction
T test for two independent samples and inductionT test for two independent samples and induction
T test for two independent samples and induction
Ā 
slides Testing of hypothesis.pptx
slides Testing  of  hypothesis.pptxslides Testing  of  hypothesis.pptx
slides Testing of hypothesis.pptx
Ā 
t-test
t-test t-test
t-test
Ā 
Crash Course in A/B testing
Crash Course in A/B testingCrash Course in A/B testing
Crash Course in A/B testing
Ā 
Randomized trials ii dr.wah
Randomized trials ii dr.wahRandomized trials ii dr.wah
Randomized trials ii dr.wah
Ā 
Student's T-Test
Student's T-TestStudent's T-Test
Student's T-Test
Ā 
Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptx
Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptxChemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptx
Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptx
Ā 
Sample size calculation
Sample size calculationSample size calculation
Sample size calculation
Ā 
An introduction to the stepped wedge cluster randomised trial
An introduction to the stepped wedge cluster randomised trial An introduction to the stepped wedge cluster randomised trial
An introduction to the stepped wedge cluster randomised trial
Ā 
A05 Continuous One Variable Stat Tests
A05 Continuous One Variable Stat TestsA05 Continuous One Variable Stat Tests
A05 Continuous One Variable Stat Tests
Ā 
A05 Continuous One Variable Stat Tests
A05 Continuous One Variable Stat TestsA05 Continuous One Variable Stat Tests
A05 Continuous One Variable Stat Tests
Ā 
The Blueprint for Success for Effective and Efficient Clinical Protocols.pptx
The Blueprint for Success for Effective and Efficient Clinical Protocols.pptxThe Blueprint for Success for Effective and Efficient Clinical Protocols.pptx
The Blueprint for Success for Effective and Efficient Clinical Protocols.pptx
Ā 
Parametric Tolerance Interval Testing
Parametric Tolerance Interval TestingParametric Tolerance Interval Testing
Parametric Tolerance Interval Testing
Ā 
Monitoring response variables 13Feb2014
Monitoring response variables 13Feb2014Monitoring response variables 13Feb2014
Monitoring response variables 13Feb2014
Ā 
Parametric test
Parametric testParametric test
Parametric test
Ā 
Overview of statistics: Statistical testing (Part I)
Overview of statistics: Statistical testing (Part I)Overview of statistics: Statistical testing (Part I)
Overview of statistics: Statistical testing (Part I)
Ā 
Test of significance
Test of significanceTest of significance
Test of significance
Ā 

More from Cytel USA

From the clinic to the cfo adaptive trials and financial decision making
From the clinic to the cfo   adaptive trials and financial decision makingFrom the clinic to the cfo   adaptive trials and financial decision making
From the clinic to the cfo adaptive trials and financial decision makingCytel USA
Ā 
Eugm 2012 pritchett - application of adaptive sample size re-estimation in ...
Eugm 2012   pritchett - application of adaptive sample size re-estimation in ...Eugm 2012   pritchett - application of adaptive sample size re-estimation in ...
Eugm 2012 pritchett - application of adaptive sample size re-estimation in ...Cytel USA
Ā 
Eugm 2012 oneill - perspective on the current environment for adaptive clin...
Eugm 2012   oneill - perspective on the current environment for adaptive clin...Eugm 2012   oneill - perspective on the current environment for adaptive clin...
Eugm 2012 oneill - perspective on the current environment for adaptive clin...Cytel USA
Ā 
Eugm 2012 mehta - future plans for east - 2012 eugm
Eugm 2012   mehta - future plans for east - 2012 eugmEugm 2012   mehta - future plans for east - 2012 eugm
Eugm 2012 mehta - future plans for east - 2012 eugmCytel USA
Ā 
Eugm 2012 jemiai - introduction to east architect
Eugm 2012   jemiai - introduction to east architectEugm 2012   jemiai - introduction to east architect
Eugm 2012 jemiai - introduction to east architectCytel USA
Ā 
Eugm 2012 demets - clinical trials and the impact of regulations
Eugm 2012   demets - clinical trials and the impact of regulationsEugm 2012   demets - clinical trials and the impact of regulations
Eugm 2012 demets - clinical trials and the impact of regulationsCytel USA
Ā 
Eugm 2011 pocock - dm cs-and-adaptive-trials
Eugm 2011   pocock - dm cs-and-adaptive-trialsEugm 2011   pocock - dm cs-and-adaptive-trials
Eugm 2011 pocock - dm cs-and-adaptive-trialsCytel USA
Ā 
Eugm 2011 mehta - execution of adaptive trials operational considerations
Eugm 2011   mehta - execution of adaptive trials operational considerationsEugm 2011   mehta - execution of adaptive trials operational considerations
Eugm 2011 mehta - execution of adaptive trials operational considerationsCytel USA
Ā 
Eugm 2011 mehta - adaptive designs for phase 3 oncology trials
Eugm 2011   mehta - adaptive designs for phase 3 oncology trialsEugm 2011   mehta - adaptive designs for phase 3 oncology trials
Eugm 2011 mehta - adaptive designs for phase 3 oncology trialsCytel USA
Ā 
EUGM 2011 | JEMIAI
EUGM 2011 | JEMIAIEUGM 2011 | JEMIAI
EUGM 2011 | JEMIAICytel USA
Ā 
EUGM 2011| Fretault | Use of bayesian approach in phase ii
EUGM 2011| Fretault | Use of bayesian approach in phase iiEUGM 2011| Fretault | Use of bayesian approach in phase ii
EUGM 2011| Fretault | Use of bayesian approach in phase iiCytel USA
Ā 
EUGM 2011 | DAY | Experiences with interim analyses and dm cs
EUGM 2011 | DAY | Experiences with interim analyses and dm csEUGM 2011 | DAY | Experiences with interim analyses and dm cs
EUGM 2011 | DAY | Experiences with interim analyses and dm csCytel USA
Ā 
EUGM 2011 | DARCHY | Deployment & use of east within sanofi r & d
EUGM 2011 | DARCHY | Deployment & use of east within sanofi r & dEUGM 2011 | DARCHY | Deployment & use of east within sanofi r & d
EUGM 2011 | DARCHY | Deployment & use of east within sanofi r & dCytel USA
Ā 
EUGM 2014 | BEKELE | Adaptive Dose Finding Using Toxicity Probability Intervals
EUGM 2014 | BEKELE | Adaptive Dose Finding Using Toxicity Probability IntervalsEUGM 2014 | BEKELE | Adaptive Dose Finding Using Toxicity Probability Intervals
EUGM 2014 | BEKELE | Adaptive Dose Finding Using Toxicity Probability IntervalsCytel USA
Ā 
EUGM 2014 | BOLOGNESE | Case Studies of Phase 2 Adaptive Dose-Finding Trials
EUGM 2014 | BOLOGNESE | Case Studies of Phase 2 Adaptive Dose-Finding TrialsEUGM 2014 | BOLOGNESE | Case Studies of Phase 2 Adaptive Dose-Finding Trials
EUGM 2014 | BOLOGNESE | Case Studies of Phase 2 Adaptive Dose-Finding TrialsCytel USA
Ā 
2012-05-30 EUGM | GAYDOS | Design & Analysis Approaches to Evaluate Cardiovas...
2012-05-30 EUGM | GAYDOS | Design & Analysis Approaches to Evaluate Cardiovas...2012-05-30 EUGM | GAYDOS | Design & Analysis Approaches to Evaluate Cardiovas...
2012-05-30 EUGM | GAYDOS | Design & Analysis Approaches to Evaluate Cardiovas...Cytel USA
Ā 
2014-10-22 EUGM | ROYCHAUDHURI | Phase I Combination Trials
2014-10-22 EUGM | ROYCHAUDHURI | Phase I Combination Trials2014-10-22 EUGM | ROYCHAUDHURI | Phase I Combination Trials
2014-10-22 EUGM | ROYCHAUDHURI | Phase I Combination TrialsCytel USA
Ā 
Clinical Proof of Concept (PoC)
Clinical Proof of Concept (PoC)Clinical Proof of Concept (PoC)
Clinical Proof of Concept (PoC)Cytel USA
Ā 
MPTI Talk
MPTI TalkMPTI Talk
MPTI TalkCytel USA
Ā 
Adaptive Phase 2 Design in Post Surgical Pain
Adaptive Phase 2 Design in Post Surgical PainAdaptive Phase 2 Design in Post Surgical Pain
Adaptive Phase 2 Design in Post Surgical PainCytel USA
Ā 

More from Cytel USA (20)

From the clinic to the cfo adaptive trials and financial decision making
From the clinic to the cfo   adaptive trials and financial decision makingFrom the clinic to the cfo   adaptive trials and financial decision making
From the clinic to the cfo adaptive trials and financial decision making
Ā 
Eugm 2012 pritchett - application of adaptive sample size re-estimation in ...
Eugm 2012   pritchett - application of adaptive sample size re-estimation in ...Eugm 2012   pritchett - application of adaptive sample size re-estimation in ...
Eugm 2012 pritchett - application of adaptive sample size re-estimation in ...
Ā 
Eugm 2012 oneill - perspective on the current environment for adaptive clin...
Eugm 2012   oneill - perspective on the current environment for adaptive clin...Eugm 2012   oneill - perspective on the current environment for adaptive clin...
Eugm 2012 oneill - perspective on the current environment for adaptive clin...
Ā 
Eugm 2012 mehta - future plans for east - 2012 eugm
Eugm 2012   mehta - future plans for east - 2012 eugmEugm 2012   mehta - future plans for east - 2012 eugm
Eugm 2012 mehta - future plans for east - 2012 eugm
Ā 
Eugm 2012 jemiai - introduction to east architect
Eugm 2012   jemiai - introduction to east architectEugm 2012   jemiai - introduction to east architect
Eugm 2012 jemiai - introduction to east architect
Ā 
Eugm 2012 demets - clinical trials and the impact of regulations
Eugm 2012   demets - clinical trials and the impact of regulationsEugm 2012   demets - clinical trials and the impact of regulations
Eugm 2012 demets - clinical trials and the impact of regulations
Ā 
Eugm 2011 pocock - dm cs-and-adaptive-trials
Eugm 2011   pocock - dm cs-and-adaptive-trialsEugm 2011   pocock - dm cs-and-adaptive-trials
Eugm 2011 pocock - dm cs-and-adaptive-trials
Ā 
Eugm 2011 mehta - execution of adaptive trials operational considerations
Eugm 2011   mehta - execution of adaptive trials operational considerationsEugm 2011   mehta - execution of adaptive trials operational considerations
Eugm 2011 mehta - execution of adaptive trials operational considerations
Ā 
Eugm 2011 mehta - adaptive designs for phase 3 oncology trials
Eugm 2011   mehta - adaptive designs for phase 3 oncology trialsEugm 2011   mehta - adaptive designs for phase 3 oncology trials
Eugm 2011 mehta - adaptive designs for phase 3 oncology trials
Ā 
EUGM 2011 | JEMIAI
EUGM 2011 | JEMIAIEUGM 2011 | JEMIAI
EUGM 2011 | JEMIAI
Ā 
EUGM 2011| Fretault | Use of bayesian approach in phase ii
EUGM 2011| Fretault | Use of bayesian approach in phase iiEUGM 2011| Fretault | Use of bayesian approach in phase ii
EUGM 2011| Fretault | Use of bayesian approach in phase ii
Ā 
EUGM 2011 | DAY | Experiences with interim analyses and dm cs
EUGM 2011 | DAY | Experiences with interim analyses and dm csEUGM 2011 | DAY | Experiences with interim analyses and dm cs
EUGM 2011 | DAY | Experiences with interim analyses and dm cs
Ā 
EUGM 2011 | DARCHY | Deployment & use of east within sanofi r & d
EUGM 2011 | DARCHY | Deployment & use of east within sanofi r & dEUGM 2011 | DARCHY | Deployment & use of east within sanofi r & d
EUGM 2011 | DARCHY | Deployment & use of east within sanofi r & d
Ā 
EUGM 2014 | BEKELE | Adaptive Dose Finding Using Toxicity Probability Intervals
EUGM 2014 | BEKELE | Adaptive Dose Finding Using Toxicity Probability IntervalsEUGM 2014 | BEKELE | Adaptive Dose Finding Using Toxicity Probability Intervals
EUGM 2014 | BEKELE | Adaptive Dose Finding Using Toxicity Probability Intervals
Ā 
EUGM 2014 | BOLOGNESE | Case Studies of Phase 2 Adaptive Dose-Finding Trials
EUGM 2014 | BOLOGNESE | Case Studies of Phase 2 Adaptive Dose-Finding TrialsEUGM 2014 | BOLOGNESE | Case Studies of Phase 2 Adaptive Dose-Finding Trials
EUGM 2014 | BOLOGNESE | Case Studies of Phase 2 Adaptive Dose-Finding Trials
Ā 
2012-05-30 EUGM | GAYDOS | Design & Analysis Approaches to Evaluate Cardiovas...
2012-05-30 EUGM | GAYDOS | Design & Analysis Approaches to Evaluate Cardiovas...2012-05-30 EUGM | GAYDOS | Design & Analysis Approaches to Evaluate Cardiovas...
2012-05-30 EUGM | GAYDOS | Design & Analysis Approaches to Evaluate Cardiovas...
Ā 
2014-10-22 EUGM | ROYCHAUDHURI | Phase I Combination Trials
2014-10-22 EUGM | ROYCHAUDHURI | Phase I Combination Trials2014-10-22 EUGM | ROYCHAUDHURI | Phase I Combination Trials
2014-10-22 EUGM | ROYCHAUDHURI | Phase I Combination Trials
Ā 
Clinical Proof of Concept (PoC)
Clinical Proof of Concept (PoC)Clinical Proof of Concept (PoC)
Clinical Proof of Concept (PoC)
Ā 
MPTI Talk
MPTI TalkMPTI Talk
MPTI Talk
Ā 
Adaptive Phase 2 Design in Post Surgical Pain
Adaptive Phase 2 Design in Post Surgical PainAdaptive Phase 2 Design in Post Surgical Pain
Adaptive Phase 2 Design in Post Surgical Pain
Ā 

Recently uploaded

Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Ā 
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...narwatsonia7
Ā 
Call Girl Number in Vashi MumbaišŸ“² 9833363713 šŸ’ž Full Night Enjoy
Call Girl Number in Vashi MumbaišŸ“² 9833363713 šŸ’ž Full Night EnjoyCall Girl Number in Vashi MumbaišŸ“² 9833363713 šŸ’ž Full Night Enjoy
Call Girl Number in Vashi MumbaišŸ“² 9833363713 šŸ’ž Full Night Enjoybabeytanya
Ā 
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Ā 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Ā 
Call Girls Service Jaipur Grishma WhatsApp ā¤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ā¤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ā¤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ā¤8445551418 VIP Call Girls Jaipurparulsinha
Ā 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Ā 
Call Girl Coimbatore Prishaā˜Žļø 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prishaā˜Žļø  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prishaā˜Žļø  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prishaā˜Žļø 8250192130 Independent Escort Service Coimbatorenarwatsonia7
Ā 
Best Rate (Hyderabad) Call Girls Jahanuma āŸŸ 8250192130 āŸŸ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma āŸŸ 8250192130 āŸŸ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma āŸŸ 8250192130 āŸŸ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma āŸŸ 8250192130 āŸŸ High Class Call Girl...astropune
Ā 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Ā 
šŸ’ŽVVIP Kolkata Call Girls ParganasšŸ©±7001035870šŸ©±Independent Girl ( Ac Rooms Avai...
šŸ’ŽVVIP Kolkata Call Girls ParganasšŸ©±7001035870šŸ©±Independent Girl ( Ac Rooms Avai...šŸ’ŽVVIP Kolkata Call Girls ParganasšŸ©±7001035870šŸ©±Independent Girl ( Ac Rooms Avai...
šŸ’ŽVVIP Kolkata Call Girls ParganasšŸ©±7001035870šŸ©±Independent Girl ( Ac Rooms Avai...Taniya Sharma
Ā 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
Ā 
VIP Service Call Girls Sindhi Colony šŸ“³ 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony šŸ“³ 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony šŸ“³ 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony šŸ“³ 7877925207 For 18+ VIP Call Girl At Th...jageshsingh5554
Ā 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
Ā 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Ā 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomdiscovermytutordmt
Ā 
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Dipal Arora
Ā 
The Most Attractive Hyderabad Call Girls Kothapet š– ‹ 6297143586 š– ‹ Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet š– ‹ 6297143586 š– ‹ Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet š– ‹ 6297143586 š– ‹ Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet š– ‹ 6297143586 š– ‹ Will You Mis...chandars293
Ā 
Call Girls Service Surat Samaira ā¤ļøšŸ‘ 8250192130 šŸ‘„ Independent Escort Service ...
Call Girls Service Surat Samaira ā¤ļøšŸ‘ 8250192130 šŸ‘„ Independent Escort Service ...Call Girls Service Surat Samaira ā¤ļøšŸ‘ 8250192130 šŸ‘„ Independent Escort Service ...
Call Girls Service Surat Samaira ā¤ļøšŸ‘ 8250192130 šŸ‘„ Independent Escort Service ...CALL GIRLS
Ā 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...indiancallgirl4rent
Ā 

Recently uploaded (20)

Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Ā 
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Ā 
Call Girl Number in Vashi MumbaišŸ“² 9833363713 šŸ’ž Full Night Enjoy
Call Girl Number in Vashi MumbaišŸ“² 9833363713 šŸ’ž Full Night EnjoyCall Girl Number in Vashi MumbaišŸ“² 9833363713 šŸ’ž Full Night Enjoy
Call Girl Number in Vashi MumbaišŸ“² 9833363713 šŸ’ž Full Night Enjoy
Ā 
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Ā 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Ā 
Call Girls Service Jaipur Grishma WhatsApp ā¤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ā¤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ā¤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ā¤8445551418 VIP Call Girls Jaipur
Ā 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Ā 
Call Girl Coimbatore Prishaā˜Žļø 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prishaā˜Žļø  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prishaā˜Žļø  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prishaā˜Žļø 8250192130 Independent Escort Service Coimbatore
Ā 
Best Rate (Hyderabad) Call Girls Jahanuma āŸŸ 8250192130 āŸŸ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma āŸŸ 8250192130 āŸŸ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma āŸŸ 8250192130 āŸŸ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma āŸŸ 8250192130 āŸŸ High Class Call Girl...
Ā 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Ā 
šŸ’ŽVVIP Kolkata Call Girls ParganasšŸ©±7001035870šŸ©±Independent Girl ( Ac Rooms Avai...
šŸ’ŽVVIP Kolkata Call Girls ParganasšŸ©±7001035870šŸ©±Independent Girl ( Ac Rooms Avai...šŸ’ŽVVIP Kolkata Call Girls ParganasšŸ©±7001035870šŸ©±Independent Girl ( Ac Rooms Avai...
šŸ’ŽVVIP Kolkata Call Girls ParganasšŸ©±7001035870šŸ©±Independent Girl ( Ac Rooms Avai...
Ā 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Ā 
VIP Service Call Girls Sindhi Colony šŸ“³ 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony šŸ“³ 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony šŸ“³ 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony šŸ“³ 7877925207 For 18+ VIP Call Girl At Th...
Ā 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Ā 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Ā 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Ā 
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Ā 
The Most Attractive Hyderabad Call Girls Kothapet š– ‹ 6297143586 š– ‹ Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet š– ‹ 6297143586 š– ‹ Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet š– ‹ 6297143586 š– ‹ Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet š– ‹ 6297143586 š– ‹ Will You Mis...
Ā 
Call Girls Service Surat Samaira ā¤ļøšŸ‘ 8250192130 šŸ‘„ Independent Escort Service ...
Call Girls Service Surat Samaira ā¤ļøšŸ‘ 8250192130 šŸ‘„ Independent Escort Service ...Call Girls Service Surat Samaira ā¤ļøšŸ‘ 8250192130 šŸ‘„ Independent Escort Service ...
Call Girls Service Surat Samaira ā¤ļøšŸ‘ 8250192130 šŸ‘„ Independent Escort Service ...
Ā 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
Ā 

2014-10-22 EUGM | PROSCHAN | Blinded Adaptations Permutations Tests and T-Tests

  • 2. IntroductionIntroduction ā€¢ Joint work with Ekkehard Glimm and MartinJointĀ workĀ withĀ Ekkehard Glimm andĀ MartinĀ  Posch 2014,Ā Stat.Ā inĀ Med.Ā onlineĀ  ā€¢ SeeĀ alsoĀ Posch &Ā Proschan 2012,Ā Stat.Ā inĀ Med.Ā  31 4146 415331,Ā 4146ā€4153
  • 3. IntroductionIntroduction ā€¢ Clinical trials are preā€meditated!ClinicalĀ trialsĀ areĀ pre meditated! ā€¢ WeĀ preā€specifyĀ everything S i it / i f i itā€“ Superiority/noninferiority ā€“ PopulationĀ (inclusion/exclusionĀ criteria) ā€“ PrimaryĀ endpoint ā€“ SecondaryĀ endpoints ā€“ AnalysisĀ methods ā€“ SampleĀ size/power
  • 4. IntroductionIntroduction ā€¢ Changes made after seeing data are rightlyChangesĀ madeĀ afterĀ seeingĀ dataĀ areĀ rightlyĀ  questioned:Ā areĀ investigatorsĀ tryingĀ toĀ getĀ anĀ  unfairĀ advantage? ā€“ ChangingĀ primaryĀ endpointĀ becauseĀ anotherĀ  endpointĀ hasĀ aĀ biggerĀ treatmentĀ effect ā€“ IncreasingĀ sampleĀ sizeĀ becauseĀ theĀ pā€valueĀ isĀ close ā€“ ChangingĀ primaryĀ analysisĀ becauseĀ ā€œassumptionsĀ  are violatedā€areĀ violated ā€“ ChangingĀ populationĀ becauseĀ ofĀ promisingĀ  subgroup resultssubgroupĀ results
  • 5. IntroductionIntroduction ā€¢ Whatā€™s the harm? 0 05 is arbitrary anywayWhat sĀ theĀ harm?Ā Ā 0.05Ā isĀ arbitraryĀ anyway ā€¢ Problem:Ā ifĀ unlimitedĀ freedomĀ toĀ changeĀ  anything the real error rate could be hugeanything,Ā theĀ realĀ errorĀ rateĀ couldĀ beĀ huge ā€¢ ReminiscentĀ ofĀ BibleĀ codeĀ controversy ā€“ ClairvoyantĀ messagesĀ suchĀ asĀ ā€œBinĀ Ladenā€Ā andĀ  ā€œtwinĀ towersā€Ā byĀ skippingĀ lettersĀ inĀ OldĀ Testament ā€“ SimilarĀ messagesĀ canĀ beĀ foundĀ byĀ skippingĀ lettersĀ  inĀ anyĀ largeĀ bookĀ (BrendanĀ McKay)
  • 6. IntroductionIntroduction ā€¢ But changes made before unblinding areButĀ changesĀ madeĀ beforeĀ unblinding areĀ  different ā€¢ Under strong null hypothesis that treatmentā€¢ UnderĀ strongĀ nullĀ hypothesis thatĀ treatmentĀ  hasĀ NO effect,Ā blindedĀ dataĀ giveĀ noĀ infoĀ aboutĀ  treatment effecttreatmentĀ effect ā€“ ImpossibleĀ toĀ cheatĀ evenĀ ifĀ itĀ seemsĀ likeĀ cheating E if bli d d d t h bi d l di t ib ti itā€¢ E.g.,Ā evenĀ ifĀ blindedĀ dataĀ showĀ bimodalĀ distribution,Ā itĀ  isĀ notĀ causedĀ byĀ treatmentĀ ifĀ strongĀ nullĀ isĀ trueĀ 
  • 7. Permutation TestsPermutationĀ Tests ā€¢ Permutation tests condition on all data otherPermutationĀ testsĀ conditionĀ onĀ allĀ dataĀ otherĀ  thanĀ treatmentĀ labels ā€¢ Under strong null (D Z ) are independentā€¢ UnderĀ strongĀ null,Ā (D,Z )Ā areĀ independent,Ā  whereĀ Z areĀ Ā±1Ā treatmentĀ indicatorsĀ &Ā DĀ areĀ  datadataĀ  ā€“ ObservedĀ dataĀ DĀ wouldĀ haveĀ beenĀ observedĀ  regardless of the treatment givenregardlessĀ ofĀ theĀ treatmentĀ given ā€“ ItĀ isĀ asĀ ifĀ weĀ observedĀ DĀ FIRST,Ā thenĀ madeĀ theĀ  treatment assignments ZtreatmentĀ assignmentsĀ Z
  • 8. Permutation TestsPermutationĀ Tests ā€¢ Peaking at data changes nothing becausePeakingĀ atĀ dataĀ changesĀ nothingĀ becauseĀ  permutationĀ testsĀ alreadyĀ conditionĀ onĀ D ā€¢ Conditional distribution of test statistic T(Z Y)ā€¢ ConditionalĀ distributionĀ ofĀ testĀ statisticĀ T(Z,Y)Ā  givenĀ DĀ isĀ thatĀ ofĀ T(Z,y)Ā whereĀ y isĀ fixed Di ib i f Z d d d i iā€¢ DistributionĀ ofĀ Z dependsĀ onĀ randomizationĀ  methodĀ  ā€“ Simple ā€“ PermutedĀ block,Ā etc.
  • 9. Permutation TestsPermutationĀ Tests T T C C C T C T C C T T C T T C 4 8 4 0 1 3 0 4 4 0 2 5 0 2 1 0 T-C T-C T-C T-C O ll T C 4.0 3.0 1.5 1.5 Overall T-C 2.5
  • 10. Permutation TestsPermutationĀ Tests T C C T C T C T T T C C C T C T 4 8 4 0 1 3 0 4 4 0 2 5 0 2 1 0 T-C T-C T-C T-C O ll T C -4.0 3.0 -1.5 0.5 Overall T-C -0.5
  • 12. Blinded 2ā€Stage ProceduresBlindedĀ 2 StageĀ Procedures ā€¢ Blinded 2ā€stage adaptive procedures use 1stBlindedĀ 2 stageĀ adaptiveĀ proceduresĀ useĀ 1stĀ Ā  stageĀ toĀ makeĀ designĀ changes ā€“ SampleĀ sizeĀ (Gould,Ā 1992,Ā Stat.Ā inĀ Med.Ā 11,Ā 55ā€66;Ā p ( , , , ; GouldĀ &Ā Shih,Ā 1992Ā Commun.Ā inĀ Stat.Ā 21,Ā 2833ā€ 2853)Ā  P i d i ( di li liā€“ PrimaryĀ endpointĀ (e.g.,Ā diastolicĀ versusĀ systolicĀ  bloodĀ pressure) ā€¢ Previous argument shows that if adaptation isā€¢ PreviousĀ argumentĀ showsĀ thatĀ ifĀ adaptationĀ isĀ  madeĀ beforeĀ unblinding,Ā aĀ permutationĀ testĀ  on 1st stage data is still validonĀ 1stĀ stageĀ dataĀ isĀ stillĀ valid
  • 13. Blinded 2ā€Stage ProceduresBlindedĀ 2 StageĀ Procedures ā€¢ Careful! Subtle errors are possibleCareful!Ā Ā SubtleĀ errorsĀ areĀ possible ā€¢ E.g.,Ā inĀ adaptiveĀ regression,Ā whichĀ ofĀ theĀ  following is (are) valid?followingĀ isĀ (are)Ā valid? 1. FromĀ ANCOVAsĀ Y=Ī²01+Ī²z+Ī²ixi,Ā i=1,ā€¦,k,Ā pickĀ xi that minimizes MSE; do permutation test onthatĀ minimizesĀ MSE;Ā doĀ permutationĀ testĀ onĀ  winner 2 From ANCOVAs Y=Ī² 1+Ī² x i=1 k pick x that2. FromĀ ANCOVAsĀ Y=Ī²01+Ī²ixi,Ā i=1,ā€¦,k,Ā pickĀ xi thatĀ  minimizesĀ MSE;Ā doĀ permutationĀ testĀ onĀ  Y=Ī²01+Ī²z+Ī²*x*,Ā whereĀ x*Ā isĀ winnerĪ²0 Ī² Ī² ,
  • 14. Blinded 2ā€Stage ProceduresBlindedĀ 2 StageĀ Procedures ā€¢ Careful! Subtle errors are possibleCareful!Ā Ā SubtleĀ errorsĀ areĀ possible ā€¢ E.g.,Ā inĀ adaptiveĀ regression,Ā whichĀ ofĀ theĀ  following is (are) valid?followingĀ isĀ (are)Ā valid? 1. FromĀ ANCOVAsĀ Y=Ī²01+Ī²z+Ī²ixi,Ā i=1,ā€¦,k,Ā pickĀ xi that minimizes MSE; do permutation test onthatĀ minimizesĀ MSE;Ā doĀ permutationĀ testĀ onĀ  winner 2 From ANCOVAs Y=Ī² 1+Ī² x i=1 k pick x that2. FromĀ ANCOVAsĀ Y=Ī²01+Ī²ixi,Ā i=1,ā€¦,k,Ā pickĀ xi thatĀ  minimizesĀ MSE;Ā doĀ permutationĀ testĀ onĀ  Y=Ī²01+Ī²z+Ī²*x*,Ā whereĀ x*Ā isĀ winnerĪ²0 Ī² Ī² ,
  • 15. Blinded 2ā€Stage ProceduresBlindedĀ 2 StageĀ Procedures ā€¢ Unblinding andĀ apparentĀ Ī±ā€inflationĀ alsoĀ possibleĀ U b d g a d appa e t Ī± at o a so poss b e ifĀ strongĀ nullĀ isĀ false ā€¢ E.g.,Ā changeĀ primaryĀ endpointĀ basedĀ onĀ ā€œblindedā€Ā g g p y p dataĀ (X,Y1,Y2),Ā Y1 andĀ Y2 areĀ potentialĀ primariesĀ  andĀ X=levelĀ ofĀ studyĀ drugĀ inĀ blood ā€“ XĀ completelyĀ unblinds ā€“ CanĀ thenĀ pickĀ Y1 orĀ Y2 withĀ biggestĀ zā€score Clearly inflates Ī±ā€“ ClearlyĀ inflatesĀ Ī± ā€“ Problem:Ā strongĀ nullĀ requiresĀ noĀ effectĀ onĀ ANY variableĀ examinedĀ (includingĀ X=levelĀ ofĀ studyĀ drug)
  • 16. Blinded 2ā€Stage ProceduresBlindedĀ 2 StageĀ Procedures ā€¢ Claim: the following procedure is validClaim:Ā theĀ followingĀ procedureĀ isĀ valid ā€“ AfterĀ viewingĀ 1stĀ stageĀ dataĀ D1,Ā chooseĀ testĀ  statistic T1(Y1 Z1) and second stage data to collectstatisticĀ T1(Y1,Z1)Ā andĀ secondĀ stageĀ dataĀ toĀ collect ā€“ AfterĀ observingĀ D2,Ā chooseĀ T2(Y2,Z2)Ā andĀ methodĀ  of combining T1 and T2, f(T1,T2)ofĀ combiningĀ T1 andĀ T2,Ā f(T1,T2) ā€“ ConditionalĀ distributionĀ ofĀ f(T1,T2)Ā givenĀ (D1,D2)Ā isĀ  itsĀ stratifiedĀ permutationĀ distributionp ā€“ StratifiedĀ permutationĀ testĀ controlsĀ conditional,Ā &Ā  thereforeĀ unconditionalĀ typeĀ IĀ errorĀ rateĀ 
  • 17. Focus of Rest of TalkFocusĀ ofĀ RestĀ ofĀ Talk ā€¢ Permutation tests are asymptoticallyPermutationĀ testsĀ areĀ asymptoticallyĀ  equivalentĀ toĀ tā€tests ā€¢ Suggests that adaptive t tests might be valid ifā€¢ SuggestsĀ thatĀ adaptiveĀ tā€testsĀ mightĀ beĀ validĀ ifĀ  adaptiveĀ permutationĀ testsĀ are W id i bā€¢ WeĀ considerĀ connectionsĀ betweenĀ  permutationĀ andĀ tā€tests,Ā andĀ validityĀ ofĀ  d i f d i iadaptiveĀ tā€testsĀ fromĀ adaptiveĀ permutationĀ  testsĀ 
  • 18. Oneā€Sample CaseOne SampleĀ Case ā€¢ CommunityĀ randomizedĀ trialsĀ sometimesĀ pairĀ Co u ty a do ed t a s so et es pa matchĀ &Ā randomizeĀ withinĀ pairs ā€¢ E.g.,Ā COMMITĀ trialĀ usedĀ communityĀ interventionĀ g y toĀ helpĀ peopleĀ quitĀ smokingā€”11Ā matchedĀ pairs ā€¢ D=differenceĀ inĀ quitĀ ratesĀ betweenĀ treatmentĀ (T)Ā  &Ā controlĀ (C) T CĀ Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā D=Tā€C PairĀ iĀ Ā Ā Ā Ā Ā Ā Ā Ā 0.30Ā Ā Ā Ā Ā 0.25Ā Ā Ā Ā Ā Ā Ā Ā +0.05
  • 19. Oneā€Sample CaseOne SampleĀ Case ā€¢ CommunityĀ randomizedĀ trialsĀ sometimesĀ pairĀ Co u ty a do ed t a s so et es pa matchĀ &Ā randomizeĀ withinĀ pairs ā€¢ E.g.,Ā COMMITĀ trialĀ usedĀ communityĀ interventionĀ g y toĀ helpĀ peopleĀ quitĀ smokingā€”11Ā matchedĀ pairs ā€¢ D=differenceĀ inĀ quitĀ ratesĀ betweenĀ treatmentĀ (T)Ā  &Ā controlĀ (C) C TĀ  D=Tā€C PairĀ iĀ Ā Ā Ā Ā Ā Ā Ā Ā 0.30Ā Ā Ā Ā Ā 0.25Ā Ā Ā Ā Ā Ā Ā Ā ā€0.05
  • 20. Oneā€Sample CaseOne SampleĀ Case ā€¢ Permuting labels changes only sign of DPermutingĀ labelsĀ changesĀ onlyĀ signĀ ofĀ D ā€¢ PermutationĀ testĀ conditionsĀ onĀ |Di|=Ā di +;Ā  d + d d + ll lik lā€di +Ā andĀ di + areĀ equallyĀ likely ā€¢ The permutation distribution of ļ“Di is dist. ofTheĀ permutationĀ distributionĀ ofĀ ļ“Di isĀ dist.Ā of 21w p1where /ZdZ ļ€­ļ€½ļƒ„ ļ€« 21w.p.1 21w.p.1where, / /ZdZ iii ļ€« ļ€½ļƒ„
  • 21. Oneā€Sample CaseOne SampleĀ Case ā€¢ InĀ 1st stage,Ā adaptĀ basedĀ onĀ |D1|,ā€¦,|Dn|Ā (blinded)g , p | 1|, ,| n| ( ) ā€“ E.g.,Ā increaseĀ stageĀ 2Ā Ā sampleĀ sizeĀ becauseĀ |Di|Ā isĀ veryĀ  large ā€¢ What is conditional distribution of 1st stage sumā€¢ WhatĀ isĀ conditionalĀ distributionĀ ofĀ Ā 1st stageĀ sumĀ  Ī£Di givenĀ |D1|=d1 +,ā€¦,|Dn|= dn + andĀ theĀ  adaptation?adaptation? ā€“ TheĀ adaptationĀ isĀ aĀ functionĀ ofĀ |D1|,ā€¦,|Dn|Ā  ā€“ TheĀ nullĀ distributionĀ ofĀ Ī£Di givenĀ |D1|=d1 +,ā€¦,|Dn|=Ā dn + i g | 1| 1 , ,| n| n ISĀ itsĀ permutationĀ distribution ā€“ Conclusion:Ā permutationĀ testĀ onĀ stageĀ 1Ā dataĀ stillĀ valid
  • 22. Oneā€Sample CaseOne SampleĀ Case ā€¢ Mean and variance of permutationMeanĀ andĀ varianceĀ ofĀ permutationĀ  distributionĀ are ļ€Ø ļ€© ļƒ„ļƒ„ ļ€½ļ€½ ļ€«ļ€« 0)(E iiii ZEddZļ€Ø ļ€© ļ€Ø ļ€© ļƒ„ļƒ„ļƒ„ ļƒ„ļƒ„ ļ€½ļ€½ļ€« 222 )(var )( iiiii iiii dZEddZ
  • 23. Oneā€Sample CaseOne SampleĀ Case ā€¢ Asymptotically,Ā permutationĀ distributionĀ isĀ sy ptot ca y, pe utat o d st but o s normalĀ withĀ thisĀ meanĀ andĀ varianceĀ (Lindebergā€ FellerĀ CLT) ā€¢ I.e.,Ā conditionalĀ distributionĀ ofĀ ļ“Di givenĀ , i g |D1|=d1 +,ā€¦,|Dn|=Ā dn + isĀ asymptoticallyĀ N(0,ļ“di 2) ā€¢ DependsĀ onĀ |D1|=d1 +,ā€¦,|Dn|=Ā dn + onlyĀ throughĀ  L2=ļ“di 2L ļ“di
  • 24. Oneā€Sample CaseOne SampleĀ Case ā€¢ Asymptotically, permutation distribution ofAsymptotically,Ā permutationĀ distributionĀ ofĀ  ļ€Ø ļ€© N d dN D D T ii 2 2 2 )1,0( ,0 ' ļ€½ļ‚»ļ€½ ļƒ„ ļƒ„ ļƒ„ ļƒ„ LD dD ii 2 ļƒ„ ļƒ„ļƒ„ n L Dns ns D T i i 2 22 02 0 )/1(;' ļ€½ļ€½ļ€½ ļƒ„ļƒ„ ā€¢ LikeĀ tā€testĀ withĀ varianceĀ estimateĀ s0 2 insteadĀ  ofĀ usualĀ sampleĀ varianceĀ s2
  • 25. Oneā€Sample CaseOne SampleĀ Case ā€¢ Recap: Permutation distribution of Tā€™ is dist ofRecap:Ā PermutationĀ distributionĀ ofĀ T isĀ distĀ ofĀ  ļƒ„ ļƒ„ļ€½ 12 |||,...,|given' n i DD D D T ļƒ„ ļƒ„ 2 i' i DT D ļ€Ø ļ€©ļƒ„ ļƒ„ļ‚» 22 2 d dtd ')10( given' i DLN DT ā€¢ Conclusion:Ā Tā€™ isĀ asymptoticallyĀ indep ofĀ L2 ļ€Ø ļ€©ļƒ„ļ€½ļ‚» 22 ondependtdoesn')1,0( iDLN
  • 26. Oneā€Sample CaseOne SampleĀ Case ā€¢ Begs question, is this true for all sample sizesBegsĀ question,Ā isĀ thisĀ trueĀ forĀ allĀ sampleĀ sizesĀ  underĀ normalityĀ assumption? ā€¢ if Di are iid N(0,ļ³2), then canifĀ Di areĀ iid N(0,ļ³ ),Ā thenĀ can ?fti d db' 2 ļƒ„ļƒ„ i D D T ?oftindependenbe' 2 2 ļƒ„ ļƒ„ ļƒ„ļ€½ i i i D D T ā€¢ SeemsĀ crazy,Ā butĀ itā€™sĀ true!
  • 27. Oneā€Sample CaseOne SampleĀ Case ā€¢ One way to see that Tā€™ is independent of ļ“Di 2OneĀ wayĀ toĀ seeĀ thatĀ T isĀ independentĀ ofĀ ļ“Di usesĀ Basuā€™s theorem:Ā  ā€¢ RecallĀ SĀ isĀ sufficient forĀ Īø ifĀ F(y|s)Ā doesĀ notĀ  d d Īø i i l if { ( )} f ll ĪødependĀ onĀ Īø;Ā itĀ isĀ complete ifĀ E{g(S)}=0Ā forĀ allĀ Īø impliesĀ g(S)ā‰”0Ā withĀ probabilityĀ 1 ā€¢ A is ancillary if its distribution does not dependā€¢ AĀ isĀ ancillary ifĀ itsĀ distributionĀ doesĀ notĀ dependĀ  onĀ Īø ā€¢ Basu,Ā 1955,Ā Sankhya 15,Ā 377ā€380: IfĀ SĀ isĀ aĀ complete,Ā sufficientĀ statisticĀ andĀ AĀ  isĀ ancillary,Ā thenĀ SĀ andĀ AĀ areĀ independent
  • 28. Oneā€Sample CaseOne SampleĀ Case ā€¢ Consider Di iid N(0 ļ³2) with ļ³2Ā unknownConsiderĀ Di iid N(0,ļ³ )Ā withĀ ļ³ unknown ā€“ļ“Di 2 isĀ completeĀ andĀ sufficient ā€“ Tā€™=Ā ļ“Di/(ļ“Di 2)1/2 isĀ ancillaryĀ becauseĀ itĀ isĀ scaleā€ invariant ā€“ ByĀ Basuā€™s theorem,Ā Tā€™ andĀ ļ“Di 2 areĀ independent
  • 29. Oneā€Sample CaseOne SampleĀ Case ā€¢ Same argument shows that the usual tā€SameĀ argumentĀ showsĀ thatĀ theĀ usualĀ t statisticĀ isĀ independentĀ ofĀ ļ“Di 2 2 2ā€¢ UnderĀ Di iid N(0,ļ³2)Ā withĀ ļ³2Ā unknown ā€“ļ“Di 2 isĀ completeĀ andĀ sufficient ā€“ UsualĀ tā€statisticĀ T=Ā ļ“Di/(ns2)1/2 isĀ ancillary ā€“ By Basuā€™s theorem T and ļ“D 2 are independentā€“ ByĀ Basu s theorem,Ā TĀ andĀ ļ“Di areĀ independentĀ  (Ā Shao (2003):Ā MathematicalĀ Statistics,Ā Springer)Ā 
  • 30. Oneā€Sample CaseOne SampleĀ Case ā€¢ This result is important for adaptive sample sizeThisĀ resultĀ isĀ important forĀ adaptiveĀ sampleĀ sizeĀ  calculations ā€“ Stage 1 with n1= half of original sample size: changeStageĀ 1Ā withĀ n1 Ā halfĀ ofĀ originalĀ sampleĀ size:Ā changeĀ  secondĀ stageĀ sampleĀ sizeĀ toĀ n2=n2(Ī£Di 2) ā€“ Conditioned on Ī£D 2:ā€“ ConditionedĀ onĀ Ī£Di :Ā  ā€¢ TestĀ statisticĀ T1 hasĀ exactĀ tā€distributionĀ withĀ n1ā€1Ā d.f. ā€¢ TestĀ statisticĀ T2 hasĀ exactĀ tā€distributionĀ withĀ n2ā€1Ā d.f. andĀ isĀ 2 2 independentĀ ofĀ T1 ā€¢ Pā€valuesĀ P1 andĀ P2 areĀ independentĀ U(0,1) ā€¢ Y={n 1/2Ī¦ā€1(P )+n 1/2Ī¦ā€1(P )}/(n +n )1/2 is N(0 1) under Hā€¢ Y={n1 1/2Ī¦ 1(P1)+n2 1/2Ī¦ 1(P2)}/(n1+n2)1/2 isĀ N(0,1)Ā underĀ H0
  • 31. Oneā€Sample CaseOne SampleĀ Case ā€¢ Reject if Y>zRejectĀ ifĀ Y>zĪ± ā€¢ ConditionedĀ onĀ Ī£Di 2,Ā typeĀ IĀ errorĀ rateĀ isĀ Ī± ā€¢ UnconditionalĀ typeĀ IĀ errorĀ rateĀ isĀ Ī± asĀ well ā€¢ Most other twoā€stage procedures are onlyMostĀ otherĀ two stageĀ proceduresĀ areĀ onlyĀ  approximate
  • 32. Oneā€Sample CaseOne SampleĀ Case ā€¢ CouldĀ evenĀ makeĀ otherĀ adaptationsĀ likeĀ changingĀ p g g primaryĀ endpoint ā€¢ LookĀ atĀ Ī£Di 2 forĀ eachĀ endpointĀ andĀ determineĀ  whichĀ oneĀ isĀ primaryĀ Ā  ļ“ 2ā€“ E.g.,Ā pickĀ endpointĀ withĀ smallestĀ ļ“Di 2 ā€¢ Slight generalization of our result shows thatā€¢ SlightĀ generalizationĀ ofĀ ourĀ resultĀ showsĀ thatĀ  conditionalĀ distributionĀ ofĀ TĀ givenĀ adaptation isĀ  stillĀ exactĀ tĀ 
  • 33. Oneā€Sample CaseOne SampleĀ Case ā€¢ Shows that conditional type I error rate givenShowsĀ thatĀ conditionalĀ typeĀ IĀ errorĀ rateĀ givenĀ  adaptationĀ isĀ controlledĀ atĀ levelĀ Ī± ā€¢ Unconditional type I error rate must also beā€¢ UnconditionalĀ typeĀ IĀ errorĀ rateĀ mustĀ alsoĀ beĀ  controlledĀ atĀ levelĀ Ī± D i i l i i liā€¢ DerivationĀ assumesĀ multivariateĀ normalityĀ  withĀ variance/covarianceĀ notĀ dependingĀ onĀ  mean
  • 34. Twoā€Sample CaseTwo SampleĀ Case ā€¢ CanĀ useĀ sameĀ reasoningĀ inĀ 2ā€sampleĀ settingĀ Ca use sa e easo g sa p e sett g ā€¢ WithĀ equalĀ sampleĀ sizes,Ā theĀ numeratorĀ is ļƒ„ļƒ„ļƒ„ YZYY ā€¢ Permutation distribution is distribution of ļƒ„ļƒ„ļƒ„ ļ€½ļ€­ ii C i T i YZYY PermutationĀ distributionĀ isĀ distributionĀ ofĀ  ļƒ„ļƒ„ ļ€½ļ‚±ļ€½ 0,1each, iiii ZZyZ ā€¢ LetĀ sL 2 beĀ ā€œlumpedā€Ā varianceĀ ofĀ allĀ dataĀ  (treatment and control)(treatmentĀ andĀ control)Ā 
  • 35. Twoā€Sample CaseTwo SampleĀ Case ā€¢ MeanĀ andĀ varianceĀ ofĀ permutationĀ distributionĀ p are ļ€Ø ļ€© 0)(EE iiii ZyyZ ļ€½ļ€½ ļƒ„ļƒ„ ļ€Ø ļ€© 22 )( 1 1 var Lii syy n yZ ļ€½ļ€­ļƒ· ļƒø ļƒ¶ ļƒ§ ļƒØ ļƒ¦ ļ€­ ļ€½ ļƒ„ļƒ„ ā€¢ Basuā€™s theoremĀ showsĀ usualĀ 2ā€sampleĀ TĀ isĀ  independent of sL 2 under null hypothesis ofindependentĀ ofĀ sL underĀ nullĀ hypothesisĀ ofĀ  commonĀ mean ā€¢ ConditionalĀ distributionĀ ofĀ TĀ givenĀ sL 2 isĀ stillĀ t
  • 36. Twoā€Sample CaseTwo SampleĀ Case ā€¢ Twoā€stage procedureTwo stageĀ procedure ā€“ StageĀ 1:Ā lookĀ atĀ lumpedĀ varianceĀ andĀ changeĀ stageĀ  2Ā sampleĀ size ā€“ ConditionedĀ onĀ 1stĀ stageĀ lumpedĀ varianceĀ &Ā H0 ā€¢ T1 hasĀ tā€distributionĀ withĀ n1ā€2Ā d.f. ā€¢ T2 hasĀ tā€distributionĀ withĀ n2ā€2Ā d.f. &Ā independentĀ ofĀ T1 ā€¢ Pā€valuesĀ P1 andĀ P2 areĀ independentĀ uniforms ā€¢ {n1 1/2Ī¦ā€1(P1)+n2 1/2Ī¦ā€1(P2)}/(n1+n2)1/2 is N(0 1) under H0{n1 Ī¦ (P1)+n2 Ī¦ (P2)}/(n1+n2) isĀ N(0,1)Ā underĀ H0 ā€“ ControlsĀ typeĀ IĀ errorĀ rateĀ conditionallyĀ andĀ  unconditionally
  • 37. SummarySummary ā€¢ Permutation tests are often valid even inPermutationĀ testsĀ areĀ oftenĀ validĀ evenĀ inĀ  adaptiveĀ settingsĀ ifĀ blindĀ isĀ maintained ā€¢ There is a close connection betweenā€¢ ThereĀ isĀ aĀ closeĀ connectionĀ betweenĀ  permutationĀ testsĀ andĀ tā€tests C d d lidi f d i fā€¢ CanĀ deduceĀ validityĀ ofĀ adaptiveĀ tā€testsĀ fromĀ  validityĀ ofĀ adaptiveĀ permutationĀ tests